Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.56+0.01 (+1.79%)
Close on Nov 18, 2026Market cap $51.83MP/E –Yield –
Citius Oncology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Citius Oncology's pe ratio was 209.0× on Oct 31, 2025, against 141.5× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 209.0× | +71.7 |
| 2024 | Dec 31, 2024 | 137.4× | – |
See a number that looks wrong?